NDC 50742-365 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 12 mg/1; Naloxone Hydrochloride 3 mg/1 · Film · Buccal, Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC50742-365

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and naloxone
Labeler
INGENUS PHARMACEUTICALS, LLC
Dosage form
Film
Route
Buccal, Sublingual
Marketing category
ANDA · ANDA212756
Marketed since
August 29, 2023
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
50742-365-3030 POUCH in 1 CARTON (50742-365-30) / 1 FILM in 1 POUCH (50742-365-01)Aug 29, 2023

Other Buprenorphine and Naloxone products